Results 151 to 160 of about 239,701 (294)
Fel d 1‐Expressing Plant‐Derived Bioparticle: A Novel Treatment for Cat Allergy
This study investigates the allergenicity and immunogenicity profile of a novel plant‐derived Fel d 1 bioparticle (eBP). Fel d 1 eBP promotes immune tolerance by redirecting allergic Th2 responses toward Th1 and IL‐10–producing regulatory pathways, including Bregs.
Janice A. Layhadi +16 more
wiley +1 more source
Editorial: Biology and pathology of tumor viruses in animals, volume II
Rui M. Gil da Costa +4 more
doaj +1 more source
Anti human papillomavirus vaccine: the checkmate to human papillomavirus?
Cervical cancer is the second most frequently found neoplasia in women worldwide. At least 95% of cervical cancers contain viral DNA which, in 80% of cases, belongs to one of the human papillomavirus (HPV) viral types at high oncogenic risk: 16, 18, 31 and 45.
MOSCARINI, Massimo +2 more
openaire +2 more sources
ABSTRACT Background Monitoring delivery of cancer care is critical to improve outcomes in increasingly resource‐constrained settings. The aim of this study was to develop a priority set of multidisciplinary quality indicators (QIs) for benchmarking and monitoring the quality of care for head and neck cancer (HNC) in Australia.
Rebecca L. Venchiarutti +17 more
wiley +1 more source
Using HPV testing and margin status alone as predictors of CIN1+ persistence/recurrence is as effective as the standard co‐test. This highlights the significance of HPV status compared to the co‐test post‐conization and indicates that HPV testing alone could be an effective follow‐up strategy for women with negative margins.
Ghina Alaref, Lone Kjeld Petersen
wiley +1 more source
The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan +11 more
wiley +1 more source
HPV vaccination in Iran: expert perspectives on family dynamics and barriers. [PDF]
Faghir-Ganji M +4 more
europepmc +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source

